Shareholding disclosure

The Swiss Helvetia Fund Inc

Declared position

5.37%

Threshold

Crossed upwards

Timeline

Published

11.08.2008

Transaction

31.07.2008

Transfer date

31.07.2008

Voting rights breakdown

Voting rights acquired5.37%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

T6514D6269

Beneficial owner

The Swiss Helvetia Fund Inc

Declared address

The Swiss Helvetia Fund Inc., New York

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

The Swiss Helvetia Fund Inc

Addex Therapeutics Ltd11.08.2008T6514D6269

Disclosure summary

The Swiss Helvetia Fund Inc disclosed a holding in Addex Therapeutics Ltd on the acquisition side, published by SIX Exchange Regulation on 11.08.2008, at 5.37% of voting rights. Notice category: Group of shareholders.

Disclosed position

5.37%

Voting rights acquired

Voting rights acquired5.37%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

The Swiss Helvetia Fund Inc disclosed a holding in Addex Therapeutics Ltd, published on 11.08.2008.

Publication date11.08.2008

Transaction date31.07.2008

Transfer date31.07.2008

Issuing companyAddex Therapeutics Ltd

Beneficial ownerThe Swiss Helvetia Fund Inc

Declared addressThe Swiss Helvetia Fund Inc., New York

CategoryGroup of shareholders

Voting rights acquired5.37%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDT6514D6269

Source: SIX Exchange Regulation · Publication date: 11.08.2008

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open